Arkadios Wealth Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$942K Sell
22,071
-14,075
-39% -$629K 0.01% 833
2026
Q1
$1.74M Buy
36,146
+315
+0.9% +$14.7K 0.03% 569
2025
Q4
$1.74M Buy
35,831
+5,058
+16% +$251K 0.03% 496
2025
Q3
$1.45M Sell
30,773
-2,063
-6% -$99.6K 0.03% 504
2025
Q2
$1.59M Buy
32,836
+11,215
+52% +$573K 0.05% 408
2025
Q1
$1.2M Buy
21,621
+16,912
+359% +$915K 0.05% 404
2024
Q4
$227K Buy
4,709
+751
+19% +$38.2K 0.01% 818
2024
Q3
$228K Buy
+3,958
New +$214K 0.01% 797
2021
Q4
Sell
-3,391
Closed -$163K 1598
2021
Q3
$163K Sell
3,391
-418
-11% -$21.3K 0.02% 558
2021
Q2
$200K Buy
3,809
+3,054
+405% +$159K 0.02% 529
2021
Q1
$37K Buy
755
+1
+0.1% +$48 0.01% 781
2020
Q4
$36K Buy
+754
New +$37.2K 0.01% 621
2020
Q2
Sell
-247
Closed -$10.8K 1124
2020
Q1
$10.8K Buy
247
+18
+8% +$861 0.01% 618
2019
Q4
$11.4K Buy
+229
New +$10.7K 0.01% 564

Other funds holding SNY

Arkadios Wealth Advisors's SNY Position: Q2 2026 in Review

Arkadios Wealth Advisors reduced its Sanofi (SNY) stake by 39% in Q2 2026, selling an estimated $629K and leaving 22,071 shares worth $942K. The position accounts for 0.01% of the portfolio, ranked #833.

Arkadios Wealth Advisors first reported a position in SNY in Q4 2019 and has held it in 14 quarters since. The position peaked at $1.74M in Q1 2026. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Arkadios Wealth Advisors held 22,071 shares of Sanofi worth $942K as of Q2 2026.
  • Arkadios Wealth Advisors sold 14,075 Sanofi shares in Q2 2026, an estimated $629K.
  • Sanofi made up 0.01% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #833 holding.
  • Arkadios Wealth Advisors first reported a position in Sanofi in Q4 2019 and has held it in 14 quarters since.
  • Arkadios Wealth Advisors's Sanofi position peaked at $1.74M in Q1 2026.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.